TWO SIGMA ADVISERS, LP - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 80 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,580,590
-12.2%
1,436,900
-1.0%
0.00%0.0%
Q1 2024$1,799,364
+20.6%
1,451,100
+2.1%
0.00%
+33.3%
Q4 2023$1,492,050
+49.2%
1,421,000
+873.3%
0.00%0.0%
Q3 2023$1,000,100
+296.9%
146,000
+500.8%
0.00%
+200.0%
Q2 2023$251,991
-23.1%
24,300
-40.0%
0.00%0.0%
Q1 2023$327,645
+69.8%
40,500
+204.5%
0.00%
Q4 2021$193,000
-34.6%
13,300
-18.9%
0.00%
-100.0%
Q3 2021$295,000
-77.0%
16,400
-77.6%
0.00%
-66.7%
Q2 2021$1,285,000
-15.5%
73,200
+21.4%
0.00%
-25.0%
Q1 2021$1,520,000
+398.4%
60,300
+27.8%
0.00%
+300.0%
Q4 2020$305,000
+408.3%
47,200
+103.4%
0.00%
Q3 2020$60,000
+42.9%
23,200
-10.4%
0.00%
Q2 2020$42,000
+16.7%
25,900
-25.4%
0.00%
Q1 2020$36,000
-67.0%
34,700
-40.1%
0.00%
Q4 2019$109,000
-34.7%
57,900
-62.6%
0.00%
Q3 2019$167,000155,0000.00%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 3,399,034$49,422,00010.17%
VR Adviser, LLC 4,563,962$66,360,0009.07%
COMMODORE CAPITAL LP 2,672,346$38,856,0009.00%
TCG Crossover Management, LLC 1,082,213$15,735,0007.37%
Foresite Capital Management V, LLC 1,258,243$18,295,0004.50%
Parkman Healthcare Partners LLC 1,025,522$14,911,0003.29%
Aisling Capital Management LP 634,455$9,225,0003.25%
GREAT POINT PARTNERS LLC 800,000$11,632,0002.58%
Samsara BioCapital, LLC 794,171$11,547,0002.24%
Affinity Asset Advisors, LLC 400,000$5,816,0002.11%
View complete list of ACLARIS THERAPEUTICS INC shareholders